Safety and immunogenicity of DT aP-HbOC in toddlers primed by DTP and HbOC as separate injections or DTP-HbOC combination vaccine
Hogerman, D.; Malinoski, F.J.; Madore, D.V.; Paradiso, P.R.
Pediatric Research 33(4 Part 2): 171A
1993
ISSN/ISBN: 0031-3998
Accession: 033289278
PDF emailed within 1 workday: $29.90
Related References
Haque, A.; Arnaud, Fçoise.; Teranishi, K.; Okada, T.; Kim, B.; Moon-Massat, P.F.; Auker, C.; McCarron, R.; Freilich, D.; Scultetus, A.H. 2012: Pre-hospital resuscitation with HBOC-201 and rFVIIa compared to HBOC-201 alone in uncontrolled hemorrhagic shock in swine Artificial Cells Blood Substitutes and Immobilization Biotechnology 40(1-2): 44-55Black, S.B.; Lewis, E.; Shinefield, H.R.; Fireman, B.; Ray, P.; DeStefano, F.; Chen, R. 2002: Lack of association between receipt of conjugate haemophilus influenzae type B vaccine (HbOC) in infancy and risk of type 1 (juvenile onset) diabetes: long term follow-up of the HbOC efficacy trial cohort Pediatric Infectious Disease Journal 21(6): 568-569
Rivera-Chavez, F.A.; Huerta, S.; Brown, R.; York, G.B.; Minei, J.P. 2007: Resuscitation from hemorrhagic shock comparing standard hemoglobin-based oxygen carrier (HBOC)-201 versus 7.5% hypertonic HBOC-201 Journal of Trauma 63(5): 1113-1119
Fukushima, Y. 2017: Genetic Counseling of HBOC and Japanese Organization of HBOC Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(2): 107-110
Shao, D.; Cheng, S.; Guo, F.; Zhu, C.; Yuan, Y.; Hu, K.; Wang, Z.; Meng, X.; Jin, X.; Xiong, Y.; Chai, X.; Li, H.; Zhang, Y.; Zhang, H.; Liu, J.; Ye, M. 2020: Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals Cancer Science 111(2): 647-657
Paradiso, P.; Hogerman, D.; Madore, D.; Keyserling, H.; King, J.; Reisinger, K.; Pennridge Pediatr Assoc (Usa).; Hackell, J. 1992: Safety and immunogenicity in infants of a tetravalent vaccine composed of hboc hibtiter and dtp tri immunol Pediatric Research 31(4 Part 2): 174A
Ohsumi, S.; Nakamura, S.; Miyata, H.; Watanabe, C.; Den, H.; Arai, M. 2022: Risk-reducing mastectomy for women with hereditary breast and ovarian cancer (HBOC): analytical results of data from the Japanese Organization of HBOC Japanese Journal of Clinical Oncology 52(11): 1265-1269
Black, S.B.; Shinefield, H.R.; Lampert, D.; Fireman, B.; Hiatt, R.A.; Polen, M.; Vittinghoff, E. 1991: Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy The Pediatric Infectious Disease Journal 10(2): 92-96
Black, S.B.; Shinefield, H.R.; Lampert, D.; Fireman, B.; Hiatt, R.A.; Polen, M.; Vittinghoff, E. 1991: Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. the Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group Pediatric Infectious Disease Journal 10(2): 92-96
Reid, R.; Santosham, M.; Croll, J.; Thompson, C.; Newcomer, W.; Siber, G.R. 1993: Antibody response of Navajo children primed with Prp-Omp vaccine to booster doses of Prp-Omp vs. HbOc vaccine The Pediatric Infectious Disease Journal 12(10): 812-814
Reid, R.; Santosham, M.; Croll, J.; Thompson, C.; Newcomer, W.; Siber, G.R. 1993: Antibody response of Navajo children primed with PRP-OMP vaccine to booster doses of PRP-OMP vs. HbOC vaccine Pediatric Infectious Disease Journal 12(10): 812-815
Schmitt, H.J.; Wirsing von König, C.H.; Zepp, F.; Huff, J.; Jahn, K.; Schmidtke, P.; Meyer, C.; Habermehl, P.; Uhlenbusch, R.; Angersbach, P. 1997: Immunogenicity and reactogenicity of HbOC vaccine administered simultaneously with acellular pertussis vaccine (DTaP) into either arms or thighs of infants Infection 25(5): 298-302
Rothstein, E.P.; Madore, D.V.; Bernstein, H.H.; Schiller, R.P.; Girone, J.A.C.; Hipp, T.J.; Souder, R.L.; Schiffman, M.S.; Kennedy, T.I.; Long, S.S. 1991: Antibody persistence four years after primary immunization of infants and toddlers with haemophilus influenzae type b crm 197 hboc conjugate vaccine Pediatric Research 29(4 Part 2): 183A
Hadida, M.; Cuevas, L.E.; Moghadami, A.; Baccoosh, M.; Gurgel, R.Q.; Hart, C.A. 1998: Immunogenicity of Haemophilus influenzae-diphtheria CRM197 protein conjugate vaccine (HbOC) in Libyan infants Tropical Medicine and International Health: Tm and Ih 3(2): 95-99
Steinhoff, M.C.; Thoms, M.L.; Dannenfelser, S.; O'donovan C. 1990: Immunogenicity of haemophilus influenzae type b crm 197 conjugate vaccine hboc given simultaneously with routine childhood immunizations Pediatric Research 27(4 Part 2): 184A
Kale, K.L.; King, J.C.; Farley, J.J.; Vink, P.E.; Cimino, C.O.; Paradiso, P.R. 1995: The immunogenicity of Haemophilus influenzae type b conjugate (HbOC) vaccine in human immunodeficiency virus-infected and uninfected infants Develomemnts in Pediatric Antiinfective Management. Symposium 14(5): 350-354
Kale, K.L.; King, J.C.; Farley, J.J.; Vink, P.E.; Cimino, C.O.; Paradiso, P.R. 1995: The immunogenicity of Haemophilus influenzae type b conjugate (HbOC) vaccine in human immunodeficiency virus-infected and uninfected infants Pediatric Infectious Disease Journal 14(5): 350-354
Black, S.B.; Shinefield, H.R.; Hiatt, R.H.; Lampert, D.; Fireman, B.; Polen, M. 1990: Safety of hboc conjugate haemophilus influenzae type b vaccine in 22450 children Pediatric Research 27(4 Part 2): 167A
Valeri, C.Robert.; Ragno, G.; Veech, R.L. 2006: Effects of the resuscitation fluid and the hemoglobin based oxygen carrier (HBOC) excipient on the toxicity of the HBOC: Ringer's D,L-lactate, Ringer's L-lactate, and Ringer's ketone solutions Artificial Cells Blood Substitutes and Immobilization Biotechnology 34(6): 601-606
Black, S.B.; Shinefield, H.R.; Ray, P.; Lewis, E.M.; Fireman, B.; Hiatt, R.; Madore, D.V.; Johnson, C.L.; Hackell, J.G. 1993: Safety of combined oligosaccharide conjugate Haemophilus influenzae type b (HbOC) and whole cell diphtheria-tetanus toxoids-pertussis vaccine in infancy. the Kaiser Permanente Pediatric Vaccine Study Group Pediatric Infectious Disease Journal 12(12): 981-985